Clinical Trial Update: Memantine to Reduce Neurocognitive Deficits Following Unilateral ECT for the Treatment of a Major Depression [NA]

View source ↗

Summary

Completed clinical trial investigating memantine to reduce neurocognitive deficits after unilateral electroconvulsive therapy for major depressive disorder; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: Stanford University | Conditions: Depressive Disorder, Major | NA | Status: COMPLETED | Results posted: 2019-09-27